These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1464415)

  • 1. Refractoriness at peripheral and pituitary receptors in general and pituitary types of thyroid hormone resistance.
    Ohzeki T; Hanaki K; Motozumi H; Matsuda-Ohtahara H; Ishitani N; Shiraki K
    Horm Metab Res; 1992 Oct; 24(10):484-7. PubMed ID: 1464415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to thyroid hormones. A disorder frequently confused with Graves' disease.
    Bantle JP; Seeling S; Mariash CN; Ulstrom RA; Oppenheimer JH
    Arch Intern Med; 1982 Oct; 142(10):1867-71. PubMed ID: 6289763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
    Gershengorn MC; Weintraub BD
    J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pituitary resistance to thyroid hormone].
    Ashizawa K; Nagataki S
    Nihon Rinsho; 1993 Oct; 51(10):2726-30. PubMed ID: 8254947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
    Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
    Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy].
    Wenzel KW
    Endokrinologie; 1975 Sep; 66(1):67-73. PubMed ID: 1243821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central hypothyroidism--various types of TSH responses to TRH stimulation.
    Trejbal D; Sulla I; Trejbalová L; Lazúrová I; Schwartz P; Machánová Y
    Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pituitary-thyroid axis in patients with pituitary disorders.
    Eskildsen PC; Kruse A; Kirkegaard C
    Horm Metab Res; 1989 Jul; 21(7):387-90. PubMed ID: 2506120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T3-release from autonomously functioning thyroid nodules in vitro.
    Poertl S; Kirner J; Saller B; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial partial peripheral and pituitary resistance to thyroid hormone: a frequently missed diagnosis?
    Hopwood NJ; Saunder SE; Shapiro B; Sisson JC
    Pediatrics; 1986 Dec; 78(6):1114-22. PubMed ID: 3097618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
    Clifton-Bligh P; Burke G
    J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized resistance to thyroid hormone (GRTH) in a family: case studies.
    Tanaka K; Sugawara A; Sakamoto M; Inoue T; Yawata A; Koshimura O; Sako Y; Sasaki S; Shimatsu A; Nakamura H
    Endocrinol Jpn; 1992 Dec; 39(6):533-8. PubMed ID: 1294371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bromocriptine administration for selective pituitary resistance to thyroid hormone.
    Ohzeki T; Hanaki K; Motozumi H; Ohtahara H; Ishitani N; Urashima H; Tsukuda T; Shiraki K; Sasaki S; Nakamura H
    Horm Res; 1993; 39(5-6):229-34. PubMed ID: 8314208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone.
    Mixson AJ; Renault JC; Ransom S; Bodenner DL; Weintraub BD
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):227-34. PubMed ID: 8384535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The syndrome of tissue resistance to thyroid hormones].
    Linquette M
    Presse Med; 1987 Jun; 16(25):1234-8. PubMed ID: 2885829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone resistance syndromes--are generalized and selective pituitary resistance part of the same disorder?
    Franklyn JA
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):235-6. PubMed ID: 8458094
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thyroid hormone resistance].
    Yamashita S; Nagataki S
    Nihon Rinsho; 1993 Jan; 51 Suppl():83-91. PubMed ID: 8459619
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei.
    Magner JA; Petrick P; Menezes-Ferreira MM; Stelling M; Weintraub BD
    J Endocrinol Invest; 1986 Dec; 9(6):459-70. PubMed ID: 3571851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.